comparemela.com
Home
Live Updates
Rastuzumab Humanised Monoclonal Antibody - Breaking News
Pages:
Latest Breaking News On - Rastuzumab humanised monoclonal antibody - Page 1 : comparemela.com
For Retina Specialists, 2024 Is a Time to Try New Tools
This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond.
United states
West virginia
Iveric bio
Abbvie allergan
Genentech roche
Pegcetacoplan syfovre
Reginal sanders
Samsung bioepis
David boyer
Los angeles
Retina society
Janssen pharmaceuticals
American society of retina specialist
Drug administration
Eyepoint pharmaceuticals
Regeneron pharmaceuticals
Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC
A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending.
United states
New york
Josep llovet
Riccardo lencioni
University of pisa
American society of clinical oncology
American society
Clinical oncology
Mount sinai hospital
Hepatocellular carcinoma hcc liver cancer of the
Angiogenesis inhibitor
Humanized monoclonal antibody
Rastuzumab humanised monoclonal antibody
Biologic therapy
Vascular endothelial growth factor
vimarsana © 2020. All Rights Reserved.